ロード中...
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
PURPOSE: Patients with uncontrolled asthma despite high doses of inhaled corticosteroid therapy plus another controller are defined as severe asthmatics. Tiotropium bromide respimat (TBR) is the only long-acting muscarinic antagonists (LAMA) approved for severe asthma. The aim of this study was to e...
保存先:
| 出版年: | J Asthma Allergy |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7667506/ https://ncbi.nlm.nih.gov/pubmed/33204116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S274245 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|